Isoflavone derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

10546470

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Isoflavones are modified by esterification at one or more of the C4', C5, C6, and C7 positions to promote bioavailability, and especially to enhance solubility over the corresponding unesterified isoflavones. Preferred modifications produce a carboxylic acid hemiester or a phosphate ester which is biologically hydrolysable. Preferred starting isoflavones are genistin and daidzin, and still more preferably comprises an aglycone form such as genistein or daidzein. Esterified isoflavones may be employed therapeutically or prophylactically for a variety of conditions, provided as a dietary supplement, or added to natural or processed food-stuffs. Further preferred uses include incorporation of contemplated compounds into topical formulations, and especially cosmetic topical formulations.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VYREXIP HOLDINGS INC2510 WARREN AVENUE SUITE 3359 CHEYENNE WY 82001

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hendler, Sheldon S La Jolla, CA 17 313
Zielinski, Jan San Diego, CA 19 209

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation